Cobolimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Cobolimab, covering 2025-09-26 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Dostarlimab and Cobolimab in Advanced Cervical Cancer [Phase 2]